Virual Oral Presentation Slide by Slide

IEEE/ICACT20260263 Slide.19        [Big Slide]	Oral Presentation
	We validated against 150 FDA-approved drugs with known metabolism pathways. Our system correctly predicted the primary metabolizing enzyme in 87% of cases, secondary pathways in 79%, and known drug-drug interactions in 84%. We also validated against clinical studies, demonstrating that our structure-based predictions translate to real patient outcomes and are ready for clinical implementation.

[Go to Next Slide]

Select Voice: Virtual Oral Presentation!!